The two regulators, Dr. Marion Gruber and Dr. Philip Krause, are stepping down in October and November, respectively, according to The New York Times.
The resignations come after weeks of an aggressive blitz by the Biden administration to encourage Americans to get a booster shot if they’ve received the Pfizer or Moderna vaccines.
Advertisement – story continues below
An @US_FDA spokesperson confirms departure of @FDACBER‘s Dr. Marion Gruber and Dr. Phil Krause
Email from Dr. Peter Marks announcing the “two retirements” calls Dr. Gruber’s departure “a huge loss” and thanks Dr. Krause for “incredible contributions to public health” https://t.co/Ko5KzfhZzc pic.twitter.com/e5aolUwQ6v
— Alexander Tin (@Alexander_Tin) August 31, 2021
Stop the censors, sign up to get today’s top stories delivered right to your inbox
Gruber, the director of the vaccines office at the FDA, and Krause, her deputy, do not believe there is enough data to justify booster shots for the public, the Times reported.
Both had reportedly seen the White House’s push for booster shots as putting unnecessary pressure on the FDA to quickly authorize the doses without the needed data.
Advertisement – story continues below
The pair were also frustrated with the Centers for Disease Control and Prevention and its advisory committee for playing a large role in decisions they believed were solely up to the FDA, CNBC reported.
Dr. Peter Marks, the FDA’s top vaccine regulator, announced in an email to employees that he would serve as acting director of the vaccines office until a permanent successor is found, according to the Times.
“Thank you so much to Marion and Phil for all that they have contributed and continue to contribute to the agency, and thanks so much to each of you for all that you do every day,” Marks wrote in the email, according to CNBC.
The White House coronavirus response coordinator, Jeffrey D. Zients, when asked by reporters about the resignations, said booster shots were dependent on FDA review.
“As our medical experts laid out, having reviewed all the available data, it is in their clinical judgment that it is time to prepare Americans for a booster shot,” Zients said in a briefing, according to the Times.
Advertisement – story continues below
The FDA is planning to hold a public panel meeting to discuss the booster shots, the outlet reported. The agency is also planning to determine whether vaccines should be made available to children under 12.
Johnson & Johnson last week became the latest company to announce the results of booster shot trials, claiming that participants had a ninefold increase in antibodies after the booster.
Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, has also reportedly discussed a recurring vaccine schedule with the White House.
Defense Secretary Lloyd Austin recently required all military service members to get vaccinated against COVID-19, but has not yet mandated the booster shots.
Advertisement – story continues below
Zients has hinted that the Biden administration is seeking to require employers to implement vaccine mandates to drive up vaccination numbers.
The FDA fully approved the Pfizer vaccine for those 16 and older last month, paving the way for vaccine mandates and possibly booster shots.
This article appeared originally on The Western Journal.